NSCLC ADENOCARCINOMA

Clinical trials for NSCLC ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new NSCLC ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for NSCLC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

Experimental immune therapy takes on Hard-to-Treat cancers

Disease control Ongoing

This early-stage trial tests an experimental drug called IMP321, which aims to boost the immune system's ability to fight cancer. It is given alongside standard treatments like chemotherapy or immunotherapy to people with advanced solid tumors that have spread. The main goals are…

Matched conditions: NSCLC ADENOCARCINOMA

Phase: PHASE1 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control

Last updated May 17, 2026 05:36 UTC

NSCLC ADENOCARCINOMA

Get alerted when new NSCLC ADENOCARCINOMA trials appear

Experimental immune therapy takes on Hard-to-Treat cancers